Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04281862
Other study ID # ATLAS2020
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date January 23, 2020
Est. completion date May 1, 2020

Study information

Verified date February 2020
Source Vance Thompson Vision
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To determine patient preference and treatment outcomes with an intracanalicular dexamethasone (0.4mg) insert compared to standard steroid drop regimen in the contralateral eye following bilateral LASIK surgery.


Description:

This prospective, open-label, single-center, randomized, investigator-sponsored clinical study seeks to investigate the outcomes of patients undergoing bilateral LASIK surgery with the treatment of a dexamethasone intracanalicular insert compared to standard of care topical prednisolone. All eyes will receive treatment. Additionally, all eyes will receive topical moxifloxacin QID for 1 week.

Twenty patient eyes undergoing bilateral LASIK surgery will be randomized to receive either Dextenza (Group A) OR standard of care prednisolone acetate 1% QID for 1 week, BID for 1 week (Group B). The contralateral eye will receive treatment with either DEXTENZA or topical prednisolone as a comparator based on randomization of first eye to Group A or Group B. Post-operative evaluations will be performed on Day 1, Day 7, and Month 1 following surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date May 1, 2020
Est. primary completion date April 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Any adult patient who is planned to undergo bilateral LASIK surgery.

- Refractive error between the 2 eyes of 2 Diopters or less

- Willing and able to comply with clinic visits and study related procedures

- Willing and able to sign the informed consent form

Exclusion Criteria:

- Patients under the age of 18.

- Patients who choose to have monovision after LASIK

- Patients with corneal pathology that may interfere with LASIK outcomes

- Patients who are pregnant (must be ruled out in women of child-bearing age with pregnancy test).

- Active infectious ocular or systemic disease.

- Patients with active infectious ocular or extraocular disease.

- Patients actively treated with local or systemic immunosuppression including systemic corticosteroids.

- Patients with known hypersensitivity to Dexamethasone.

- Patients with severe disease that warrants critical attention, deemed unsafe for the study by the investigator.

- Patients with a history of ocular inflammation or macular edema.

- Patients with allergy or inability to receive topical antibiotic.

- Patients on systemic non-steroidal anti-inflammatory drugs (NSAID) greater than 1,200 mg/day

- Patients with a corticosteroid implant (i.e. Ozurdex).

- Active or history of chronic or recurrent inflammatory eye disease in either eye

- Ocular pain in either eye

- Proliferative diabetic retinopathy in either eye

- Significant macular pathology detected on macular optical coherence tomography evaluation at the screening visit in either eye

- Laser or incisional ocular surgery during the study period and 6 months prior in either eye

- History of cauterization of the punctum

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Dextenza 0.4Mg Ophthalmic Insert
The insert, containing 0.4 mg of active pharmaceutical product, is placed within the canaliculus to provide a sustained and tapered delivery of drug to the ocular surface over 30 days after a one-time insertion. The attributes of the insert reduce the risks for improper corticosteroid tapering and unwanted peaks and troughs in drug concentration.
Topical Prednisolone
Standard of care topical drop treatment

Locations

Country Name City State
United States Vance Thompson Vision ND W. Fargo North Dakota

Sponsors (1)

Lead Sponsor Collaborator
Vance Thompson Vision

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Safety Endpoints As measured by intraocular pressure increase of 10 mm Hg or greater from baseline. Through Month 1 (Day 28 +/- 3 days)
Other Safety Endpoints As measured by proportion of eyes rescued with additional topical prednisolone treatment or increased frequency of dosing. Through Month 1 (Day 28 +/- 3 days)
Other Safety Endpoints As measured by occurrence of adverse events. Through Month 1 (Day 28 +/- 3 days)
Primary Patient Preference As measured by COMTOL adapted survey. Through Month 1 (Day 28 +/- 3 days)
Primary Patient Comfort As measured by SPEED Questionnaire. Through Month 1 (Day 28 +/- 3 days)
Secondary Ocular Surface Health As measured by corneal staining. Through Month 1 (Day 28 +/- 3 days)
Secondary Visual Outcomes As measured by uncorrected Visual Acuity. Through Month 1 (Day 28 +/- 3 days)
Secondary Ocular Pain As measured by Ocular Pain Assessment. Through Month 1 (Day 28 +/- 3 days)
See also
  Status Clinical Trial Phase
Completed NCT00565695 - Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction N/A
Completed NCT05406973 - Comparison Between the SBK Microkeratome Versus Femtosecond Laser in Flap Creation During LASIK Surgery for Myopia N/A
Active, not recruiting NCT05658718 - Factors Influencing Nocturnal Symptoms After Refractive Surgery.
Recruiting NCT06448468 - Analysis of Ocular Surface Microbiota in Dry Eye Patients After Refractive Surgery
Withdrawn NCT00466908 - Accuracy of the Pentacam and IOL Master to Calculate the Effective Corneal Power After Corneal Refractive Surgery
Completed NCT05060094 - Comparison of Outcomes Between TransPRK and Off-flap Epi-LASIK
Completed NCT04396990 - The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study
Completed NCT03938883 - Ocular Bandage Gel (OBG) Pivotal Trial in Patients Undergoing Photorefractive Keratectomy ("PRK") N/A
Completed NCT03791684 - Accelerated Versus Standard CXL in the Treatment of Ectasia Post Refractive Surgery and Penetrating Keratoplasty. N/A
Completed NCT04684888 - Femto-flap Versus SBK Flap,Predictability and Variability N/A
Recruiting NCT06264804 - Risk Factors for Progressive Suction Loss in Corneal Refractive Surgery
Completed NCT03569423 - Comparison Between TPRK Versus AAPRK in Correction of Myopia N/A
Recruiting NCT02614625 - Spectral-domain Optical Coherence Tomography of the Eye N/A
Completed NCT04899258 - Evaluation of the Effect of Myopic Femtosecond Laser Assisted-LASIK on Anterior Chamber Flare Values and Corneal Endothelial Cells: A Prospective Before-and-After Study N/A
Completed NCT00742950 - Refractive Change Induced by 2.8-mm Corneal Incision N/A
Completed NCT03597906 - Topography Guided LASIK by Different Protocols for Treatment of Astigmatism N/A
Recruiting NCT05037370 - CONTOURA vs WFO Ablation PRK & LASIK N/A